Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer

Background: In recent years, tumor immunotherapy has become a viable treatment option for triple negative breast cancer (TNBC). Among these, immune checkpoint inhibitors (ICIs) have demonstrated good efficacy in advanced TNBC patients with programmed death-ligand 1 (PD-L1) positive expression. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Qiaorui, Chi, Yajing, Su, Mu, Zhou, Jinxing, Zhou, Dongdong, Zheng, Fangchao, Man, Xiaochu, Sun, Shujuan, Huang, Jie, Li, Huihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060982/
https://www.ncbi.nlm.nih.gov/pubmed/37007962
http://dx.doi.org/10.3389/fgene.2023.1125970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060982/
https://www.ncbi.nlm.nih.gov/pubmed/37007962
http://dx.doi.org/10.3389/fgene.2023.1125970

Ejemplares similares